Host-Specific Driving Force in Human Immunodeficiency Virus Type 1 Evolution In Vivo

Size: px
Start display at page:

Download "Host-Specific Driving Force in Human Immunodeficiency Virus Type 1 Evolution In Vivo"

Transcription

1 JOURNAL OF VIROLOGY, Mar. 1997, p Vol. 71, No X/97/$ Copyright 1997, American Society for Microbiology Host-Specific Driving Force in Human Immunodeficiency Virus Type 1 Evolution In Vivo LINQI ZHANG, 1 * RICARDO S. DIAZ, 2 DAVID D. HO, 1 JAMES W. MOSLEY, 3 MICHAEL P. BUSCH, 2 AND ALLEN MAYER 1,2 Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York ; Irwin Memorial Blood Centers, San Francisco, California ; and Transfusion Safety Study, University of Southern California School of Medicine, Los Angeles, California Received 31 May 1996/Accepted 9 December 1996 To investigate the process of human immunodeficiency virus type 1 (HIV-1) evolution in vivo, a total of 179 HIV-1 V3 sequences derived from cell-free plasma were determined from serial samples in three epidemiologically linked individuals (one infected blood donor and two transfusion recipients) over a maximum period of 8 years. A systematic analysis of pairwise comparisons of intrapatient sequences, both within and between each sample time point, revealed a preponderance and accumulation of nonsynonymous rather than synonymous substitutions in the V3 loop and flanking regions as they diverged over time. This strongly argues for the dominant role that positive selection for amino acid change plays in governing the pattern and process of HIV-1 env V3 evolution in vivo and nullifies hypotheses of purely neutral or mutation-driven evolution or completely chance events. In addition, different rates of evolution of HIV-1 were observed in these three different individuals infected with the same viral strain, suggesting that the degree of positive pressure for HIV-1 amino acid change is host dependent. Finally, the observed similar rate of accumulation in divergence within and between infected individuals suggests that the process of genetic divergence in the HIV epidemic proceeds regardless of host-to-host transmission events, i.e., that transmission does not reset the evolutionary clock. A striking feature of human immunodeficiency virus type 1 (HIV-1) in vivo infection is the rapid generation and turnover of viral variants, resulting in a high degree of sequence diversity within and between infected individuals (5, 7, 10, 16, 18, 20, 21, 26, 33, 38, 40, 41). The rapid dynamics of HIV-1 replication in vivo is likely to be a consequence of intrinsic properties of the virus, such as a high replication rate and substantial numbers of viral progeny produced per replication cycle (8, 15, 39). The cause of the high degree of sequence diversity in vivo, however, is much less well understood. It is fairly clear that the error-prone nature of the viral reverse transcriptase provides the biochemical basis for the observed viral variation. What determines the ultimate fate of a mutated variant genome, however, is controversial. One viewpoint is that the accumulation of specific variants is largely determined by their relative fitness in a given selective environment. Immune surveillance (16, 20, 26, 34, 41) and viral cell tropism (4, 31, 37) are examples of plausible selective forces that may be shaping HIV diversity in vivo. Others discount the role of selection at the amino acid level and propose that the observed diversity could result from mutation-driven evolution (36), neutral evolution (14), or simply chance antigenic stimulation of lymphocytes carrying resident variant proviruses (38). Evidence that supports the existence of some degree of selective pressure on the V3 region of HIV-1 env comes from analyses of K a and K s values and the K a /K s ratio of sequence pairs, where K a is the observed frequency of nonsynonymous substitutions per replacement site and K s is the observed frequency of synonymous substitutions per silent site (22 24, 28, 32, 33). The higher the value of K a or K s, the more divergence there is between a pair * Corresponding author. Mailing address: Aaron Diamond AIDS Research Center, Rockefeller University, 455 First Ave., 7th Floor, New York, NY Phone: (212) Fax: (212) lzhang@adarc.org. of sequences, and the higher the K a /K s ratio, the stronger the selection pressure for amino acid change. To quantify and assess the temporal pattern of selective constraints that might underlie the process of HIV-1 evolution in vivo, Bonhoeffer and colleagues (2) used HIV-1 plasma V3 sequence data from samples collected from an HIV-1-infected hemophiliac over a 7-year time period. These sequences were analyzed in terms of the changes in K a, K s, and the K a /K s ratio within each sampling point. The K s value within each sampling point was seen to increase over time, whereas the K a value remained roughly the same. Consequently, the K a /K s ratio within each sampling point decreased over time, which is interpreted as being due to a gradually weakening selective pressure for amino acid sequence change as the patient s CD4 counts dropped (2). A circumstance consisting of the transfusion in 1985 of components derived from the same HIV-1-contaminated unit of blood into two recipients, followed by the enrollment of the donor and recipients in the Transfusion Safety Study (11), has allowed us to compare the evolution of the same HIV-1 strain in three different hosts, namely, the two recipients (A and B) and the actual blood donor. The V3 regions of genomes present in sequential plasma samples obtained from these three epidemiologically linked individuals over a maximum period of 8 years were sequenced (10a). To assess the intensity and pattern of the selective constraints exerted by different individuals on the same viral strain, we have used this sequence data to calculate both intra- and intersample K a, K s, and the K a /K s values. Details of the donor and the two patients, the transfusion event, and the sequential samples obtained from them as part of the Transfusion Safety Study (11) up to 8 years after the transfusion are given elsewhere (10a). A total of 179 HIV-1 RNA genomes derived from cell-free plasma were PCR amplified for the V3 region after reverse transcription, as described in detail in reference 10a. V3 region sequences were 2555

2 2556 NOTES J. VIROL. Downloaded from FIG. 1. The amino acid alignments of donor (a), recipient A (b), and recipient B (c) sequences are shown aligned with the consensus sequence obtained from the donation sample in 1985 (D85-con). Dots represent amino acid identity to the consensus, dashes indicate gaps introduced to preserve the alignment, and pound signs represent sites of synonymous substitutions. Nonsynonymous substitutions are indicated by lowercase letters. The V3 loop is highlighted. This figure is a modified version of Fig. 2 in reference 10a. on October 5, 2018 by guest obtained by direct sequencing of nested PCR products derived from single cdna molecules. Ten genomes were obtained from the serum of the original donated unit of blood, 53 genomes were obtained from six sequential donor follow-up plasma samples, 57 genomes were obtained from five sequential recipient A plasma samples, and 59 genomes were obtained from six sequential recipient B plasma samples (Gen- Bank accession numbers U29433 to U29437, U29956 and U29957, U29959 to U30074, U30077 to U30145, U31573 to U31582, and U43035 to U43054). The 237-nucleotide-long sequences covered the entire V3 loop as well as flanking regions. The average frequencies of synonymous (K s ) and nonsynonymous (K a ) nucleotide substitutions for all pairwise sequence comparisons, both within and between samples, were calculated by the methods of Nei and Gojobori (29) and Li et al. (24). Because results obtained by these two methods were similar, only those calculated by the former method were used in the analysis. Intra- and intersample genetic distances were calculated with the program DNADIST, implemented in the PHYLIP package (version 3.5) (12). The Jukes-Cantor model of molecular evolution was used to correct for multiple substitutions in observed genetic distance, as well as in K a and K s

3 VOL. 71, 1997 NOTES 2557 Downloaded from (29). Regression curves were constructed by the program Curve Fitting, implemented in the DeltaGraph package (version 3.0) (9), and correlation coefficients (r values) were estimated by the principle of least squares (9). The amino acid alignments of the sequences from the donor and the two recipients are shown in Fig. 1 to highlight both synonymous and nonsynonymous changes. As discussed by Diaz et al. (10a), the general pattern seen is one of individualspecific divergence, but there are some common amino acid changes in the different individuals. No unusual mutations or foci of mutations with respect to published sequences are prominent. A phylogenetic study demonstrated that early sequences cluster around the origin of the tree whereas sequences from later time points are more distant (10a). The average number of nucleotide substitutions per nonsynonymous site (K a ) and per synonymous site (K s ) for all pairwise comparisons of sequences within each sampling point were calculated for the donor and the two transfusion recipients, the same method used in the study by Bonhoeffer et al. (2). The FIG. 1 Continued. means of intrasample K a, K s, and K a /K s values are shown in Fig. 2a to c, respectively, plotted versus the time at which the samples were collected. The intrasample K s values for the three individuals fluctuate substantially without a steady increase or decrease over time (Fig. 2b). This is different from the gradual increase observed in the individual studied by Bonhoeffer et al. (2). The intrasample K a values in our three individuals appear to increase with time, and they drop off late in recipient B. This contrasts with the relatively stable K a value in the individual in the study by Bonhoeffer et al. (2). The intrasample K a /K s ratios fluctuate with time like K s values, although there is a minor tendency toward an increase over time (K a /K s 1 during the later years of infection). The lack of concordance between the results from this study and those from the study by Bonhoeffer et al. (2) might be due to differences in host factors or, alternatively, the analytic approach used. In an attempt to explore the second possibility, we chose to go beyond the snapshot measurement provided by the intrasample K a and K s values to the calculation of the on October 5, 2018 by guest

4 2558 NOTES J. VIROL. Downloaded from FIG. 1 Continued. on October 5, 2018 by guest intersample K a and K s values obtained by pairwise comparison of sequences belonging to samples obtained at different times (termed rk a and rk s ). The means of intersample rk a and rk s values for the three individuals (one donor and two recipients) were plotted as a function of corresponding nucleotide divergence, calculated under the Jukes-Cantor model of molecular evolution (29). By using this approach, the relative contributions of nonsynonymous and synonymous changes to the overall nucleotide divergence can be readily estimated. The results are shown in Fig. 3, which demonstrates a strong linear correlation between the rk a values and genetic divergence for all three individuals. The r value for rk a and genetic divergence is highly significant, reaching 0.99 (P 0.001) in the donor and in recipient A and 0.96 (P 0.001) in recipient B. In contrast, the relatedness between rk s and genetic divergence is minimal. The r values for rk s and genetic divergence are all relatively small in both recipients A (0.15, P 0.10) and B (0.29, P 0.10), although a weak correlation can be seen in the donor (0.66, P 0.01). It is also interesting to note that in cases where genetic divergence is relatively small, rk s values are about the same as the corresponding rk a values. However, when the overall genetic divergence increases, rk a increases at a much faster rate than rk s. As a result, rk a values gradually surpass rk s values and become the dominant contributor to the overall genetic divergence (Fig. 3). The observed pattern is consistent with the notion that selective pressure in these three individuals actively promotes amino acid changes in the V3 loop and flanking regions. To investigate the temporal pattern of divergence over time in these three individuals, rk a,rk s, and genetic distance were

5 VOL. 71, 1997 NOTES 2559 FIG. 2. Average intrasample K a, K s, and K a /K s values from plasma-derived HIV-1 RNA sequences obtained from three epidemiologically linked individuals over the time period of the study. The open circles, squares, and crosses represent samples collected from the donor, recipient A, and recipient B, respectively. Each point represents the average value obtained from pairwise sequence comparisons within a particular sample. plotted versus time, using pairwise comparisons between the first and all subsequent samples of each individual. Figure 4 demonstrates the linear regression lines for rk a,rk s, and genetic distance versus time in the donor and the two recipients, A and B. Strong linear correlations for rk a and genetic distance were observed, showing an increase with time. The linear correlations shown are strongly supported by the high r values in all three of the individuals analyzed. With regard to the regression curve for rk a and time, the r value is 0.94 (P 0.001) in the donor, 0.98 (P 0.001) in recipient A, and 0.91 (P 0.001) in recipient B, whereas for genetic distance and time, the r value is as high as 0.94 (P 0.001) in the donor, 0.98 (P 0.001) in recipient A, and 0.91 (P 0.001) in recipient B. A linear correlation between rk s and time, on the other hand, is much less apparent, with r values of 0.83 in the donor, 0.42 in recipient A, and 0.67 in recipient B. The linear correlations between both rk a and genetic divergence and time suggest that the entire intrapatient viral population, as far as the V3 loop and flanking regions are concerned, progressively diverges away from the initial viral inoculum without significant back mutation to, or reappearance of, previous sequences. The linear relationships obtained by this type of analysis facilitate quantitative comparisons between different individuals. When the slopes of the rk a and genetic distance curves in Fig. 4 for the three different individuals are compared, differences are noted, indicating different evolutionary paces of HIV-1 V3 sequences within the different hosts. The slopes of the rk a regression lines for the donor and for recipients A and B are 0.007, 0.009, and 0.013, respectively, and the respective values for genetic distance are 0.007, 0.007, and The rates of amino acid and nucleotide change in recipient B are therefore approximately 1.7 times faster than those in the donor and recipient A. The different pace of viral evolution in recipient B, although this individual was initially infected with the same viral strain as the donor and recipient A, argues for the existence of different intensities of selective pressure in different individuals. In summary, we have analyzed the evolution of the hypervariable V3 region of a single HIV-1 strain over time in three epidemiologically related infected individuals. The existence, temporal pattern, and relative strength of positive pressure for HIV-1 amino acid change within the different individuals were assessed by calculating the relative contributions of nonsynonymous and synonymous nucleotide changes to V3 genotypic divergence over time. We observed marked fluctuations over time in the values of K s, K a, and K a /K s calculated from intrasample sequence comparisons for the three individuals belonging to this epidemiological cluster, which makes quantitation and comparison between the different individuals difficult. We show instead that plotting intersample rk a values versus time yields linear curves that are better suited for interpatient comparisons. Furthermore, plotting the intersample rk a and rk s values versus genetic divergence effectively demonstrates the predominant contribution of nonsynonymous rather than synonymous changes to the V3 nucleotide sequence divergence shown by this particular HIV-1 strain within all three of the individuals infected by it. If this strain is representative of HIV-1 in general, then selective pressure appears to be the dominant driving force for V3 sequence evolution leading to the vast diversification in FIG. 3. The average values of the frequencies of intersample synonymous (rk s ) (open squares) and nonsynonymous (rk a ) (solid circles) substitutions plotted versus total genetic distance in the donor, recipient A, (RA), and recipient B (RB). Each point represents the average value obtained from pairwise comparisons of sequences for two samples from a given individual. The ranges of the standard deviations (SD) for rk a and rk s were comparable (donor: SD rka, 0.7 to 3.8%, and SD rks, 1.3 to 2.9%; recipient A: SD rka, 0.7 to 2.7%, and SD rks, 1.1 to 2.4%; recipient B: SD rka, 0.6 to 3.3%, and SD rks, 1.5 to 3.3%).

6 2560 NOTES J. VIROL. FIG. 4. The average values of the frequencies of intersample synonymous (rk s ) (open squares) and nonsynonymous (rk a ) (solid circles) substitutions and genetic distances (open triangles) relative to the first available sample over the time period of the study. Each point represents the average value obtained from pairwise comparisons between sequences in each subsequent sample and sequences in the first sample. RA, recipient A; RB, recipient B. viral quasispecies in vivo (1, 5, 7, 10, 16, 18, 20, 21, 25, 26, 33, 34, 40, 41). If HIV diversity was instead largely a manifestation of purely neutral evolution (14), mutation-driven evolution (36), or completely random events (38), then one would not expect to see a more significant correlation between rk a and time than between rk s and time over the course of infection. The preponderance of nonsynonymous substitutions observed and the rapid turnover of the viral population observed by Ho et al. (15) and Wei et al. (39) make it clearly inappropriate to apply neutral and chance theory to the evolutionary process of HIV-1. The rapid accumulation of nonsynonymous substitutions in other retroviruses and RNA viruses, such as simian immunodeficiency virus (3) and foot-and-mouth disease virus (13), also argues for a similar nonneutral process of viral evolution in vivo. In addition, the observation here that the slopes of the rk a regression versus time curves are not all the same in these three individuals infected with the same viral strain suggests that the selective pressure for V3 region amino acid change is host dependent. A similar conclusion was reached from an analysis of HIV-1 proviral DNA from two time points per person in a cluster of five epidemiologically linked transfusion recipients (40). However, the correlation between the selective pressure for amino acid change and the rate of clinical progression is not clear-cut, since recipient A, who showed a more moderate clinical progression and V3 amino acid change than recipient B, showed about the same pressure for divergence as the donor, who did not progress clinically over the course of the study (10a). A study by Lukashov et al. (25) comparing two sequences, one obtained during seroconversion and one determined 5 years later, from each of 44 individuals showed a positive correlation between the length of the immunocompetent period (CD4 counts 200) and the degree of nonsynonymous substitution, suggesting that slower progressors have stronger selective pressures for amino acid change. However, in five HIV-1-infected infants, Strunnikova et al. (35) found an inverse correlation between average CD4 cell counts and the rate of sequence divergence. In a recent study of six patients, two moderate progressors and one slow progressor showed higher rates of nonsynonymous changes than one slow progressor and two rapid progressors (41). It must be emphasized that our population consists of only three patients and that they were not selected to represent extremes with regard to rate of clinical progression. The relationship between the rate of sequence divergence and CD4 cell decline warrants further study. Our results do not directly address the issue of the nature of the force for selection, be it related to immune escape or to the acquisition of a wider cellular host range for the virus within the infected individual. If the pressure for amino acid change is due to immune selection, then at least for the three individuals studied here, sharing the same viral strain, there was no clear-cut correlation between the degree of immune selection and the time to onset of immunodeficiency. Due to the significant linear correlation between genetic distance and time in these three individuals, we ventured further to estimate the rate of genetic divergence within each of the study subjects. The slopes of the genetic distance regression curves yield average rates of increase in genetic divergence per year of 0.7% in the donor, 0.7% in recipient A, and 1.2% in recipient B. The overall average among these three individuals is therefore 0.87% per year, which is in fact very similar to the rate of nucleotide divergence (1.10% per year) calculated from a large cross-sectional sequence data set (19, 20, 27, 28). The observed rate of variation is also surprisingly similar to that seen in macaques experimentally infected with molecularly cloned simian immunodeficiency virus (3, 17). The similar rates of accumulation of divergence within and between infected individuals suggests that the process of genetic divergence in the HIV epidemic proceeds regardless of host-to-host transmission events, i.e., that transmission does not reset the evolutionary clock. Thus, the homogeneous viral population observed during seroconversion (6, 30, 42, 43) may not be the result of selection back to a common universal transmission sequence but rather may be due to selection for a particular viral phenotype within a given incoming viral population. Indeed, distinct viral sequences that share a predominantly macrophage-tropic phenotype have been obtained from different individuals during seroconversion (6, 30, 43). The sequences of these transmitted viral genomes would be predicted to have evolved away from their ancestral sequence at a rate of about 1% per year, particularly during the early course of the HIV-1 epidemic in the human population. We thank Steve Wolinsky, Andrew Leigh Brown, and Sebastian Bonhoeffer for critical reading of the manuscript. Financial support for the collection and documentation of the subjects and their specimens was provided by contracts NO1-HB-47002, NO1-HB-47003, and NO1-HB from the NHLBI and is gratefully acknowledged. The sequencing was supported by NHLBI grant RO1-HL The visit by R.S.D. to Irwin Memorial Blood Centers was funded by the Fogarty International Program through the University of California, Berkeley. REFERENCES 1. Balfe, P., P. Simmonds, C. A. Ludlam, J. O. Bishop, and A. J. Leigh Brown Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low

7 VOL. 71, 1997 NOTES 2561 frequency of inactivating mutations. J. Virol. 64: Bonhoeffer, S., E. Holmes, and M. Nowak Causes of HIV diversity. Nature 376: Burns, D. P. W., and R. C. Desrosiers Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J. Virol. 65: Cheng-Mayer, C., D. Seto, M. Tateno, and J. Levy Biological features of HIV-1 that correlate with virulence in the host. Science 240: Cichutek, K., H. Merget, S. Norley, R. Linde, W. Kreuz, M. Gahr, and R. Kurth Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc. Natl. Acad. Sci. USA 89: Cichutek, K., S. Norley, R. Linde, W. Kreuz, M. Gahr, J. Lower, V. von Wangenheim, and R. Kurth Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a mutative biologic clone of HIV-1. AIDS 5: Coffin, J Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176: Coffin, J HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267: DeltaGraph Deltapoint, Inc., Monterey, Calif. 10. Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goudsmit, and J. I. Mullins Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68: a.Diaz, R. S., L. Zhang, M. P. Busch, J. W. Mosley, and A. Mayer. AIDS, in press. 11. Donegan, E., M. Stuart, J. C. Niland, H. S. Sacks, S. P. Azen, S. L. Dietrich, C. Faucett, M. A. Fletcher, S. H. Kleinman, E. A. Operskalski, H. A. Perkins, J. Pindyck, E. R. Schiff, D. P. Stites, P. A. Tomasulo, and J. W. Mosley Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann. Intern. Med. 113: Felsenstein, J PHYLIP manual, version 3.5. Department of Genetics, University of Washington, Seattle. 13. Gebauer, F., J. C. de la Torre, I. Gomes, M. G. Mateu, H. Barahona, B. Tiraboschi, I. Bergmann, P. Augé de Mello, and E. Domingo Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J. Virol. 62: Gojobori, T., E. N. Moriyama, and M. Kimura Molecular clock of viral evolution, and the neutral theory. Proc. Natl. Acad. Sci. USA 87: Ho, D. D., A. Neumann, A. Perelson, W. Chen, J. M. Leonard, and M. Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: Holmes, E. C., L. Zhang, P. Simmonds, C. A. Ludlam, and A. J. Leigh Brown Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Natl. Acad. Sci. USA 89: Johnson, P. R., T. E. Hamm, S. Goldstein, S. Kitov, and V. M. Hirsch The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology 185: Korber, B. T. M., E. E. Allen, A. D. Farmer, and G. L. Myers Heterogeneity of HIV-1 and HIV-2. AIDS 9(Suppl. A):S5 S Kuiken, C. L., V. V. Lukashov, E. Baan, J. Dekker, J. A. M. Leunissen, and J. Goudsmit Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the Amsterdam population. AIDS 10: Kuiken, C. L., G. Zwart, E. Baan, R. A. Coutinho, J. A. R. van del Hoek, and J. Goudsmit Increasing antigenic and genetic diversity of the HIV-1 V3 domain in the course of the AIDS epidemic. Proc. Natl. Acad. Sci. USA 90: LaRosa, G. J., J. P. Davide, K. Weinhold, J. A. Waterbury, A. T. Prosy, J. A. Lewis, A. J. Langlois, G. R. Dreesman, R. N. Boswell, and B. P. Shadduck Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249: Leigh Brown, A. J., and P. Monaghan Evolution of the structural proteins of human immunodeficiency virus: selective constraints on nucleotide substitution. AIDS Res. Hum. Retroviruses 4: Li, W. H., and D. Graur Fundamentals of molecular evolution. Sinauer Associates, Inc., Sunderland, Mass. 24. Li, W. H., C. I. Wu, and C. C. Luo A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol. Biol. Evol. 2: Lukashov, V. V., C. L. Kuiken, and J. Goudsmit Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J. Virol. 69: McNearney, T., A. Hornickova, R. Markhan, A. Birdwell, M. Arens, A. Saah, and L. Ratner Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA 89: Myers, G., K. MacInnes, and B. Korber The emergence of simian/ human immunodeficiency viruses. AIDS Res. Hum. Retroviruses 8: Myers, G., and G. N. Pavlakis Evolutionary potential of complex retroviruses, p In J. A. Levy (ed.), The retroviruses. Plenum Press, New York, N.Y. 29. Nei, M., and T. Gojobori Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3: Roos, M. T. L., J. M. A. Lange, R. E. Y. Goede, R. A. Coutinho, P. T. A. Schellekens, F. Miedema, and M. Tersmette Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 165: Schiutemaker, H., M. Koot, N. A. Kootstra, M. W. Dercksen, R. E. Y. de Goede, R. P. van Steenwijk, J. M. A. Lange, J. K. M. Eeftink Schattenkerk, F. Miedema, and M. Tersmette Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66: Shpaer, E. G., and J. I. Mullins Rates of amino acid changes in the envelope protein correlate with pathogencicity of primate lentiviruses. J. Mol. Evol. 37: Simmonds, P., P. Balfe, C. A. Ludlam, J. O. Bishop, and A. J. Leigh Brown Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J. Virol. 64: Simmonds, P., L. Q. Zhang, F. McOmish, P. Balfe, C. A. Ludlam, and A. J. Leigh Brown Discontinuous sequence changes of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyteassociated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol. 65: Strunnikova, N., S. C. Ray, R. A. Livingston, E. Rubalcaba, and R. P. Viscidi Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. J. Virol. 69: Temin, H. W Is HIV unique or merely different? J. Acquired Immune Defic. Syndr. 2: Tersmette, M., J. M. Lange, R. E. de Goede, F. de Wolf, J. K. M. Eeftink Schattenkerk, P. T. Schellekens, R. A. Coutinho, J. G. Huisman, J. Goudsmit, and F. Miedema Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i: Wain-Hobson, S Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr. Top. Microbiol. Immunol. 176: Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. Hahn, M. S. Saag, and G. M. Shaw Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: Wolfs, T. F., J. J. de Jong, H. Van den Berg, J. M. Tijnagel, W. J. Krone, and J. Goudsmit Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus type 1 is host dependent, rapid, and continuous. Proc. Natl. Acad. Sci. USA 87: Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 272: Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. Leigh Brown, and P. Simmonds Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67: Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:

Monte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies

Monte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies Monte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies Jack da Silva North Carolina Supercomputing Center, MCNC, Research Triangle Park, NC; jdasilva@ncsc.org Austin Hughes Department

More information

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside UvA-DARE (Digital Academic Repository) RNAi based gene therapy for HIV-1, from bench to bedside Von Eije, K.J. Link to publication Citation for published version (APA): Von Eije, K. J. (2009). RNAi based

More information

The molecular clock of HIV-1 unveiled through analysis of a known transmission history

The molecular clock of HIV-1 unveiled through analysis of a known transmission history Proc. Natl. Acad. Sci. USA Vol. 96, pp. 10752 10757, September 1999 Evolution The molecular clock of HIV-1 unveiled through analysis of a known transmission history THOMAS LEITNER, AND JAN ALBERT Theoretical

More information

attempts to assess in vitro the fitness of sequential V3 loop isolates by serological techniques (19) and to examine patterns

attempts to assess in vitro the fitness of sequential V3 loop isolates by serological techniques (19) and to examine patterns Proc. Nati. Acad. Sci. USA Vol. 89, pp. 4835-4839, June 1992 Evolution Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single

More information

To test the possible source of the HBV infection outside the study family, we searched the Genbank

To test the possible source of the HBV infection outside the study family, we searched the Genbank Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),

More information

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Anne Piantadosi 1,2[, Bhavna Chohan 1,2[, Vrasha Chohan 3, R. Scott McClelland 3,4,5, Julie Overbaugh 1,2* 1 Division of Human

More information

An Evolutionary Story about HIV

An Evolutionary Story about HIV An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst

More information

Host-Specific Modulation of the Selective Constraints Driving Human Immunodeficiency Virus Type 1 env Gene Evolution

Host-Specific Modulation of the Selective Constraints Driving Human Immunodeficiency Virus Type 1 env Gene Evolution JOURNAL OF VIROLOGY, May 1999, p. 3764 3777 Vol. 73, No. 5 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Host-Specific Modulation of the Selective Constraints

More information

Evolution of hepatitis C virus in blood donors and their respective recipients

Evolution of hepatitis C virus in blood donors and their respective recipients Journal of General Virology (2003), 84, 441 446 DOI 10.1099/vir.0.18642-0 Short Communication Correspondence Jean-François Cantaloube jfc-ets-ap@gulliver.fr Evolution of hepatitis C virus in blood donors

More information

HIV Anti-HIV Neutralizing Antibodies

HIV Anti-HIV Neutralizing Antibodies ,**/ The Japanese Society for AIDS Research The Journal of AIDS Research : HIV HIV Anti-HIV Neutralizing Antibodies * Junji SHIBATA and Shuzo MATSUSHITA * Division of Clinical Retrovirology and Infectious

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES 1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.

More information

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan JOURNAL OF VIROLOGY, May 2000, p. 4335 4350 Vol. 74, No. 9 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Reevaluation of Amino Acid Variability of the Human

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

Macrophage-tropic Variants Initiate Human Immunodeficiency Virus Type 1 Infection after Sexual, Parenteral, and Vertical Transmission

Macrophage-tropic Variants Initiate Human Immunodeficiency Virus Type 1 Infection after Sexual, Parenteral, and Vertical Transmission Macrophage-tropic Variants Initiate Human Immunodeficiency Virus Type 1 Infection after Sexual, Parenteral, and Vertical Transmission Ang6lique B. van't Wout,* Neeltje A. Kootstra,* Greetje A. Mulder-Kampinga,*

More information

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group) AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,

More information

Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline

Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Proc. Natl. Acad. Sci. USA Vol. 95, pp. 12568 12573, October 1998 Medical Sciences Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline RICHARD B. MARKHAM*, WEI-CINN WANG*,

More information

Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution.

Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Brian T. Foley, PhD btf@lanl.gov HIV Genetic Sequences, Immunology, Drug Resistance and Vaccine Trials

More information

Originally published as:

Originally published as: Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681

More information

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview

More information

Received 4 August 2005/Accepted 7 December 2005

Received 4 August 2005/Accepted 7 December 2005 JOURNAL OF VIROLOGY, Mar. 2006, p. 2472 2482 Vol. 80, No. 5 0022-538X/06/$08.00 0 doi:10.1128/jvi.80.5.2472 2482.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Extensive Recombination

More information

Correlation analysis between CD4 T Cell counts and genetic diversity indicate no relationship Mia Huddleston and Anindita Varshneya

Correlation analysis between CD4 T Cell counts and genetic diversity indicate no relationship Mia Huddleston and Anindita Varshneya Correlation analysis between CD4 T Cell counts and genetic diversity indicate no relationship Mia Huddleston and Anindita Varshneya Department of Biology Loyola Marymount University October 11, 2016 Outline

More information

COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1

COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1 Journal of Cell and Tissue Research Vol. 10(3) 2359-2364 (2010) ISSN: 0973-0028 (Available online at www.tcrjournals.com) Original Article COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN

More information

HIV-1 acute infection: evidence for selection?

HIV-1 acute infection: evidence for selection? HIV-1 acute infection: evidence for selection? ROLLAND Morgane University of Washington Cohort & data S6 S5 T4 S4 T2 S2 T1 S1 S7 T3 DPS (days post symptoms) 3 (Fiebig I) 7 (Fiebig I) 13 (Fiebig V) 14 (Fiebig

More information

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter Prevention of infection 2 : immunisation How infection influences the host : viruses Peter Balfe, p.balfe@bham.ac.uk @pbalfeuk Let s have some LO s just for fun 1. Define the Immune response to viruses,

More information

Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence

Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence Courtney Merriam and Shivum Desai Biology 368: Bioinformatics Loyola Marymount

More information

Lecture 11. Immunology and disease: parasite antigenic diversity

Lecture 11. Immunology and disease: parasite antigenic diversity Lecture 11 Immunology and disease: parasite antigenic diversity RNAi interference video and tutorial (you are responsible for this material, so check it out.) http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html

More information

An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008

An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008 An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs Debrah Boeras Emory University October 14, 2008 Background A majority of HIV-1 infections occur through heterosexual exposure

More information

T Leitner, S Kumar and J Albert. Updated information and services can be found at:

T Leitner, S Kumar and J Albert. Updated information and services can be found at: Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history. T Leitner, S Kumar and J Albert J. Virol.

More information

Rama Nada. - Malik

Rama Nada. - Malik - 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect

More information

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa

Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length

More information

Search for the Mechanism of Genetic Variation in the pro Gene of Human Immunodeficiency Virus

Search for the Mechanism of Genetic Variation in the pro Gene of Human Immunodeficiency Virus JOURNAL OF VIROLOGY, Oct. 1999, p. 8167 8178 Vol. 73, No. 10 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Search for the Mechanism of Genetic Variation

More information

HIV 101: Fundamentals of HIV Infection

HIV 101: Fundamentals of HIV Infection HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able

More information

Evidence for enteroviral persistence in humans

Evidence for enteroviral persistence in humans Journal of General Virology (1997), 78, 307 312. Printed in Great Britain...... SHORT COMMUNICATION Evidence for enteroviral persistence in humans Daniel N. Galbraith, Carron Nairn and Geoffrey B. Clements

More information

Virus Genetic Diversity

Virus Genetic Diversity Virus Genetic Diversity Jin-Ching Lee, Ph.D. 李 jclee@kmu.edu.tw http://jclee.dlearn.kmu.edu.t jclee.dlearn.kmu.edu.tw TEL: 2369 Office: N1024 Faculty of Biotechnology Kaohsiung Medical University Outline

More information

NIH Public Access Author Manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2013 September 01.

NIH Public Access Author Manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2013 September 01. NIH Public Access Author Manuscript Published in final edited form as: J Acquir Immune Defic Syndr. 2012 September 1; 61(1): 19 22. doi:10.1097/qai.0b013e318264460f. Evaluation of HIV-1 Ambiguous Nucleotide

More information

Received 6 November 1997/Accepted 23 February 1998

Received 6 November 1997/Accepted 23 February 1998 JOURNAL OF VIROLOGY, June 1998, p. 5099 5107 Vol. 72, No. 6 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Evolution of Syncytium-Inducing and Non-Syncytium-Inducing Biological

More information

Low ds/dn Does Not Correlate With High Variation of Amino Acid Sequences Along the gp120 Protein Structure

Low ds/dn Does Not Correlate With High Variation of Amino Acid Sequences Along the gp120 Protein Structure Low ds/dn Does Not Correlate With High Variation of Amino Acid Sequences Along the gp120 Protein Structure Zach Goldstein & Jordan Detamore BIOL 368: Bioinformatics Laboratory Department of Biology Loyola

More information

Edinburgh Research Explorer

Edinburgh Research Explorer Edinburgh Research Explorer Genetic drift and within-host metapopulation dynamics of HIV-1 infection Citation for published version: Frost, SDW, Dumaurier, MJ, Wain-Hobson, S & Leigh Brown, AJ 2001, 'Genetic

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease

More information

Genomic Quasispecies Associated with the Initiation of Infection and Disease in Ponies Experimentally Infected with Equine Infectious Anemia Virus

Genomic Quasispecies Associated with the Initiation of Infection and Disease in Ponies Experimentally Infected with Equine Infectious Anemia Virus JOURNAL OF VIROLOGY, June 1996, p. 3346 3354 Vol. 70, No. 6 0022-538X/96/$04.00 0 Copyright 1996, American Society for Microbiology Genomic Quasispecies Associated with the Initiation of Infection and

More information

Patterns of hemagglutinin evolution and the epidemiology of influenza

Patterns of hemagglutinin evolution and the epidemiology of influenza 2 8 US Annual Mortality Rate All causes Infectious Disease Patterns of hemagglutinin evolution and the epidemiology of influenza DIMACS Working Group on Genetics and Evolution of Pathogens, 25 Nov 3 Deaths

More information

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein

Exploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein Microbes Count! 137 Video IV: Reading the Code of Life Human Immunodeficiency Virus (HIV), like other retroviruses, has a much higher mutation rate than is typically found in organisms that do not go through

More information

Mapping the Antigenic and Genetic Evolution of Influenza Virus

Mapping the Antigenic and Genetic Evolution of Influenza Virus Mapping the Antigenic and Genetic Evolution of Influenza Virus Derek J. Smith, Alan S. Lapedes, Jan C. de Jong, Theo M. Bestebroer, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Ron A. M. Fouchier Science

More information

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of

More information

Stochastic Interplay between Mutation and Recombination during the Acquisition of Drug Resistance Mutations in Human Immunodeficiency Virus Type 1

Stochastic Interplay between Mutation and Recombination during the Acquisition of Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 JOURNAL OF VIROLOGY, Nov. 2005, p. 13572 13578 Vol. 79, No. 21 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.21.13572 13578.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Stochastic

More information

X/01/$ DOI: /JVI Copyright 2001, American Society for Microbiology. All Rights Reserved.

X/01/$ DOI: /JVI Copyright 2001, American Society for Microbiology. All Rights Reserved. JOURNAL OF VIROLOGY, Apr. 2001, p. 3753 3765 Vol. 75, No. 8 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.8.3753 3765.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Route of Simian

More information

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit

More information

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS Somda&a Sinha Indian Institute of Science, Education & Research Mohali, INDIA International Visiting Research Fellow, Peter Wall Institute

More information

On an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures

On an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures HIV-1 evolution in response to immune selection pressures BISC 441 guest lecture Zabrina Brumme, Ph.D. Assistant Professor, Faculty of Health Sciences Simon Fraser University http://www3.niaid.nih.gov/topics/hivaids/understanding/biology/structure.htm

More information

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Modeling the Antigenic Evolution of Influenza Viruses from Sequences Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.

More information

Nonsynonymous Amino Acid Mutations in gp120 Binding Sites are Related to Progression of HIV-1

Nonsynonymous Amino Acid Mutations in gp120 Binding Sites are Related to Progression of HIV-1 Nonsynonymous Amino Acid Mutations in gp120 Binding Sites are Related to Progression of HIV-1 Matthew Allegretti and Anindita Varshneya BIOL 368: Bioinformatics Laboratory Loyola Marymount University November

More information

Identification of New Influenza B Virus Variants by Multiplex Reverse Transcription-PCR and the Heteroduplex Mobility Assay

Identification of New Influenza B Virus Variants by Multiplex Reverse Transcription-PCR and the Heteroduplex Mobility Assay JOURNAL OF CLINICAL MICROBIOLOGY, June 1998, p. 1544 1548 Vol. 26, No. 6 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Identification of New Influenza B Virus Variants by Multiplex

More information

Rajesh Kannangai Phone: ; Fax: ; *Corresponding author

Rajesh Kannangai   Phone: ; Fax: ; *Corresponding author Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal

More information

Julianne Edwards. Retroviruses. Spring 2010

Julianne Edwards. Retroviruses. Spring 2010 Retroviruses Spring 2010 A retrovirus can simply be referred to as an infectious particle which replicates backwards even though there are many different types of retroviruses. More specifically, a retrovirus

More information

The use of nonhuman primates in biomedical research has led to the isolation of many

The use of nonhuman primates in biomedical research has led to the isolation of many JVI Accepts, published online ahead of print on 29 September 2010 J. Virol. doi:10.1128/jvi.01928-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Gkikas Magiorkinis, 1 Dimitrios Paraskevis, 1 Anne-Mieke Vandamme, 2 Emmanouil Magiorkinis, 1 Vana Sypsa 1 and Angelos Hatzakis 1 INTRODUCTION

Gkikas Magiorkinis, 1 Dimitrios Paraskevis, 1 Anne-Mieke Vandamme, 2 Emmanouil Magiorkinis, 1 Vana Sypsa 1 and Angelos Hatzakis 1 INTRODUCTION Journal of General Virology (2003), 84, 2715 2722 DOI 10.1099/vir.0.19180-0 In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation

More information

Biological Phenotype of Human Immunodeficiency Virus Type 1

Biological Phenotype of Human Immunodeficiency Virus Type 1 JOURNAL OF VIROLOGY, Mar. 1992, p. 1354-1360 0022-538X/92/031354-07$02.00/0 Copyright 1992, American Society for Microbiology Vol. 66, No. 3 Biological Phenotype of Human Immunodeficiency Virus Type 1

More information

Phenotypic and Genotypic Characteristics of Human Immunodeficiency Virus Type 1 from Patients with AIDS in Northern Thailand

Phenotypic and Genotypic Characteristics of Human Immunodeficiency Virus Type 1 from Patients with AIDS in Northern Thailand JOURNAL OF VIROLOGY, Aug. 1995, p. 4649 4655 Vol. 69, No. 8 0022-538X/95/$04.00 0 Copyright 1995, American Society for Microbiology Phenotypic and Genotypic Characteristics of Human Immunodeficiency Virus

More information

A Statistical Characterization of Consistent Patterns of Human Immunodeficiency Virus Evolution Within Infected Patients

A Statistical Characterization of Consistent Patterns of Human Immunodeficiency Virus Evolution Within Infected Patients A Statistical Characterization of Consistent Patterns of Human Immunodeficiency Virus Evolution Within Infected Patients Scott Williamson,* Steven M. Perry, Carlos D. Bustamante,* Maria E. Orive, Miles

More information

SURVEILLANCE TECHNICAL

SURVEILLANCE TECHNICAL CHAPTER 5 SURVEILLANCE TECHNICAL ASPECTS 55 Protect - detect - protect Polio eradication strategies can be summed up as protect and detect protect children against polio by vaccinating them, and detect

More information

What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome

What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome What is influenza virus? 13,000 base RNA genome: 1/246153 the size of the human genome CDC Principles of Virology, 4e Neumann et al. Nature. 2009. Influenza virus is one of the most deadly viral pathogens

More information

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1 Epidemiology 227 April 24, 2009 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 60 questions and 9 pages on the examination. Each question will count one point.

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus

Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus JOURNAL OF VIROLOGY, Oct. 2004, p. 11340 11351 Vol. 78, No. 20 0022-538X/04/$08.00 0 DOI: 10.1128/JVI.78.20.11340 11351.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Predicting

More information

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Leander Schietgat 1, Kristof Theys 2, Jan Ramon 1, Hendrik Blockeel 1, and Anne-Mieke Vandamme

More information

The HIV Clock. Introduction. SimBio Virtual Labs

The HIV Clock. Introduction. SimBio Virtual Labs SimBio Virtual Labs The HIV Clock Introduction AIDS is a new disease. This pandemic, which has so far killed over 25 million people, was first recognized by medical professionals in 1981. The virus responsible

More information

GOVX-B11: A Clade B HIV Vaccine for the Developed World

GOVX-B11: A Clade B HIV Vaccine for the Developed World GeoVax Labs, Inc. 19 Lake Park Drive Suite 3 Atlanta, GA 3 (678) 384-72 GOVX-B11: A Clade B HIV Vaccine for the Developed World Executive summary: GOVX-B11 is a Clade B HIV vaccine targeted for use in

More information

bs148h 6 September 2007 Read: Text pgs , ch 22 & 23

bs148h 6 September 2007 Read: Text pgs , ch 22 & 23 bs148h 6 September 2007 Read: Text pgs 436-437, ch 22 & 23 phenotypic variation selection within generations heritability across generations phenotypic response across generations partitioning variance:

More information

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4

More information

The Swarm: Causes and consequences of HIV quasispecies diversity

The Swarm: Causes and consequences of HIV quasispecies diversity The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008 Mutation, mutation, mutation Success of HIV largely due to its ability

More information

0.1 Immunology - HIV/AIDS. 0.2 History & biology of HIV

0.1 Immunology - HIV/AIDS. 0.2 History & biology of HIV 0.1 mmunology - HV/ADS n our previous models we assumed a homogeneous population where everyone was susceptible and infectious to the same degree. n contrast, the dynamics of STDs is affected by the general

More information

7.014 Problem Set 7 Solutions

7.014 Problem Set 7 Solutions MIT Department of Biology 7.014 Introductory Biology, Spring 2005 7.014 Problem Set 7 Solutions Question 1 Part A Antigen binding site Antigen binding site Variable region Light chain Light chain Variable

More information

A Robust Measure of HIV-1 Population Turnover Within Chronically Infected Individuals

A Robust Measure of HIV-1 Population Turnover Within Chronically Infected Individuals A Robust Measure of HIV-1 Population Turnover Within Chronically Infected Individuals G. Achaz,* S. Palmer, M. Kearney, F. Maldarelli, J. W. Mellors,à J. M. Coffin, and J. Wakeley* *Department of Organismic

More information

EVOLUTION. Reading. Research in my Lab. Who am I? The Unifying Concept in Biology. Professor Carol Lee. On your Notecards please write the following:

EVOLUTION. Reading. Research in my Lab. Who am I? The Unifying Concept in Biology. Professor Carol Lee. On your Notecards please write the following: Evolution 410 9/5/18 On your Notecards please write the following: EVOLUTION (1) Name (2) Year (3) Major (4) Courses taken in Biology (4) Career goals (5) Email address (6) Why am I taking this class?

More information

Chapter 19: The Genetics of Viruses and Bacteria

Chapter 19: The Genetics of Viruses and Bacteria Chapter 19: The Genetics of Viruses and Bacteria What is Microbiology? Microbiology is the science that studies microorganisms = living things that are too small to be seen with the naked eye Microorganisms

More information

numbe r Done by Corrected by Doctor

numbe r Done by Corrected by Doctor numbe r 5 Done by Mustafa Khader Corrected by Mahdi Sharawi Doctor Ashraf Khasawneh Viral Replication Mechanisms: (Protein Synthesis) 1. Monocistronic Method: All human cells practice the monocistronic

More information

Virology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment.

Virology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment. DEVH Virology Introduction Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment. Definitions Virology: The science which study the

More information

A new wild-type in the era of transmitted drug resistance

A new wild-type in the era of transmitted drug resistance A new wild-type in the era of transmitted drug resistance EHR 2018 Rome KU Leuven 1 A new wild-type in the era of transmitted drug resistance? KU Leuven 2 Measurably evolving viruses Evolutionary rate

More information

From Mosquitos to Humans: Genetic evolution of Zika Virus

From Mosquitos to Humans: Genetic evolution of Zika Virus Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical

More information

Multiple sequence alignment

Multiple sequence alignment Multiple sequence alignment Bas. Dutilh Systems Biology: Bioinformatic Data Analysis Utrecht University, February 18 th 2016 Protein alignments We have seen how to create a pairwise alignment of two sequences

More information

It is well known that some pathogenic microbes undergo

It is well known that some pathogenic microbes undergo Colloquium Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution Robin M. Bush, Catherine B. Smith, Nancy J. Cox, and Walter M. Fitch Department of

More information

Ebola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017

Ebola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017 Ebola Virus Emerging Diseases Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017 Outline Disease emergence: a case study How do pathogens shift hosts? Evolution within hosts: The evolution

More information

SUPPLEMENTARY FIG. S1. MVC inhibition curves in NP2-CD4/CCR5 cells. Luciferase reporter viruses pseudotyped with baseline (black solid lines) and MVC

SUPPLEMENTARY FIG. S1. MVC inhibition curves in NP2-CD4/CCR5 cells. Luciferase reporter viruses pseudotyped with baseline (black solid lines) and MVC Supplementary Data SUPPLEMENTARY FIG. S1. MVC inhibition curves in NP2-CD4/CCR5 cells. Luciferase reporter viruses pseudotyped with baseline (black solid lines) and MVC failure Envs (black dotted lines)

More information

What makes the transmitted HIV-1 in newly infected patients unique from the donor inoculum?

What makes the transmitted HIV-1 in newly infected patients unique from the donor inoculum? What makes the transmitted HIV-1 in newly infected patients unique from the donor inoculum? What happens during primary infection? Los Alamos National Laboratories Evidence of the genetic bottleneck at

More information

Decay characteristics of HIV-1- infected compartments during combination therapy

Decay characteristics of HIV-1- infected compartments during combination therapy Decay characteristics of HIV-1- infected compartments during combination therapy Perelson et al. 1997 Kelsey Collins BIOL0380 September 28, 2009 SUMMARY Analyzed decay patterns of viral load of HIV- 1-infected

More information

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan International Congress Series 1263 (2004) 749 753 Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan Shin ichi Shimada a, *, Takayasu Ohtsuka b, Masayuki Tanaka b, Munehito

More information

CD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120

CD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120 CD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120 Colin Wikholm and Isai Lopez BIOL 368: Bioinformatics Laboratory Department of Biology Loyola Marymount University November 15,

More information

HIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense

HIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense Micro 320: Infectious Disease & Defense HIV/AIDS & Immune Evasion Strategies Wilmore Webley Dept. of Microbiology The Year 1981 Reported by MS Gottlieb, MD, HM Schanker, MD, PT Fan, MD, A Saxon, MD, JD

More information

NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar

NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY S. Van Borm, I. Monne, D. King and T. Rosseel 16th International WAVLD symposium, 10th OIE Seminar 07.06.2013 Viral livestock

More information

Ongoing HIV Replication During ART Reconsidered

Ongoing HIV Replication During ART Reconsidered Open Forum Infectious Diseases PERSPECTIVES Ongoing HIV Replication During ART Reconsidered Mary F. Kearney, 1 Ann Wiegand, 1 Wei Shao, 2 William R. McManus, 1 Michael J. Bale, 1 Brian Luke, 2 Frank Maldarelli,

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia 1 of 7 I. Diseases Caused by Retroviruses RETROVIRUSES A. Human retroviruses that cause cancers 1. HTLV-I causes adult T-cell leukemia and tropical spastic paraparesis 2. HTLV-II causes hairy T-cell leukemia

More information

7.012 Quiz 3 Answers

7.012 Quiz 3 Answers MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Notes 1: accuracy of prediction algorithms for peptide binding affinities to HLA and Mamu alleles For each HLA and Mamu allele we have analyzed the accuracy of four predictive algorithms

More information

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute Understanding HIV Transmission Utilizing Transmitted/Founder Viruses Brandon Keele SAIC-Frederick National Cancer Institute AIDS Vaccine 2011 15 September 2011 Overview Several years ago, the CHAVI sought

More information

Maternal oral CMV recurrence following postnatal primary infection in infants

Maternal oral CMV recurrence following postnatal primary infection in infants Maternal oral CMV recurrence following postnatal primary infection in infants I. Boucoiran, B. T. Mayer, E. Krantz, S. Boppana, A. Wald, L. Corey, C.Casper, J. T. Schiffer, S. Gantt No conflict of interest

More information

HIV Life Cycle & Genetics

HIV Life Cycle & Genetics HIV Life Cycle & enetics! etroviruses (and transposable elements) appear to be part of every cell's genome! From bacteria to yeast, flies, fish, and humans! ome endogenous retroviruses (most notably in

More information

Sequence analysis for VP4 of enterovirus 71 isolated in Beijing during 2007 to 2008

Sequence analysis for VP4 of enterovirus 71 isolated in Beijing during 2007 to 2008 16 2009 3 4 1 Journal of Microbes and Infection, March 2009, Vol. 4, No. 1 2007 2008 71 VP4 1, 2, 2, 2, 1, 2, 2, 2, 1, 2 1., 100730; 2., 100020 : 2007 2008 71 ( EV71), 2007 3 EV71( 1, 2 ) 2008 5 EV71(

More information

Clinical utility of NGS for the detection of HIV and HCV resistance

Clinical utility of NGS for the detection of HIV and HCV resistance 18 th Annual Resistance and Antiviral Therapy Meeting v Professor Janke Schinkel Academic Medical Centre, Amsterdam, The Netherlands Thursday 18 September 2014, Royal College of Physicians, London Clinical

More information